Variation in Restarting Antithrombotic Drugs at Hospital Discharge After Intracerebral Hemorrhage

Abstract

The variation in clinical practice and lack of consistent associations with restarting antithrombotic drugs after ICH reflect current knowledge and support the need for randomized controlled trials to resolve this dilemma.